ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)
- 1 September 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 324 (8401) , 483-486
- https://doi.org/10.1016/s0140-6736(84)92564-9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Allogeneic Bone‐Marrow TransplantationImmunological Reviews, 1983
- Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cellsBlood, 1983
- Bone marrow transplantation across major histocompatibility barriers in miceClinical Immunology and Immunopathology, 1982
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.Proceedings of the National Academy of Sciences, 1978
- Anti‐lymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti‐brain antibodies on acute secondary disease in miceEuropean Journal of Immunology, 1974
- MODIFICATION OF SEVERE GRAFT-VERSUS-HOST DISEASE WITH ANTISERA TO THE θ ANTIGEN OR TO WHOLE SERUMTransplantation, 1973
- METHOTREXATE REGIMENS FOR CONTROL OF GRAFT-VERSUS-HOST DISEASE IN DOGS WITH ALLOGENEIC MARROW GRAFTSTransplantation, 1970
- THE SELECTIVE ELIMINATION OF IMMUNOLOGICALLY COMPETENT CELLS FROM BONE MARROW AND LYMPHATIC CELL MIXTURES II. MOUSE SPLEEN CELL FRACTIONATION ON A DISCONTINUOUS ALBUMIN GRADIENTTransplantation, 1968